Literature DB >> 15814903

Perinatal exposure to antiretroviral agents: risks and benefits.

Gwendolyn B Scott.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15814903      PMCID： PMC7977142     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  28 in total

1.  Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine.

Authors:  I C Hanson; T A Antonelli; R S Sperling; J M Oleske; E Cooper; M Culnane; M G Fowler; L A Kalish; S S Lee; G McSherry; L Mofenson; D E Shapiro
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-04-15

2.  Repeat injuries in an inner city population--Philadelphia, 1987-1988.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-01-12       Impact factor: 17.586

3.  Trends in perinatal transmission of HIV/AIDS in the United States.

Authors:  M L Lindegren; R H Byers; P Thomas; S F Davis; B Caldwell; M Rogers; M Gwinn; J W Ward; P L Fleming
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

4.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

5.  Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.

Authors: 
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

6.  Human immunodeficiency virus-related cancer in children: incidence and treatment outcome--report of the Italian Register.

Authors:  D Caselli; C Klersy; M de Martino; C Gabiano; L Galli; P A Tovo; M Aricò
Journal:  J Clin Oncol       Date:  2000-11-15       Impact factor: 44.544

7.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors:  L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

8.  Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

Authors:  J P Ioannidis; E J Abrams; A Ammann; M Bulterys; J J Goedert; L Gray; B T Korber; M J Mayaux; L M Mofenson; M L Newell; D E Shapiro; J P Teglas; C M Wilfert
Journal:  J Infect Dis       Date:  2001-01-12       Impact factor: 5.226

9.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

10.  Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

Authors:  E R Stiehm; J S Lambert; L M Mofenson; J Bethel; J Whitehouse; R Nugent; J Moye; M Glenn Fowler; B J Mathieson; P Reichelderfer; G J Nemo; J Korelitz; W A Meyer; C V Sapan; E Jimenez; J Gandia; G Scott; M J O'Sullivan; A Kovacs; A Stek; W T Shearer; H Hammill
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.